Literature DB >> 31105849

miR-4513 promotes breast cancer progression through targeting TRIM3.

Yongzhen Li1, Huifang Zhu1, Jianqiang Wang1, Xinlai Qian1, Na Li1.   

Abstract

The biological function of microRNA-4513 (miR-4513) in human cancers is emerging. However, it remains unknown whether miR-4513 has a role in breast cancer (BC). In this study, we analyzed the expression of miR-4513 and tripartite motif containing 3 (TRIM3) in BC cell lines. The biological roles of miR-4513 and TRIM3 in BC were analyzed by cell counting kit-8 assay, colony formation assay, wound healing assay, and transwell invasion assay. The effects of miR-4513 or TRIM3 expression on the overall survival of BC patients were analyzed at Kaplan-Meier plotter website. We found miR-4513 expression was upregulated, whereas TRIM3 expression was downregulated in BC cell lines. Importantly, high miR-4513 or low TRIM3 expression was revealed as predictors for poorer overall survival of BC patients. Luciferase activity assay and western blot assay revealed TRIM3 was a direct target of miR-4513. Moreover, we showed miR-4513 was able to regulate BC cell proliferation, colony formation, cell migration, and cell invasion through regulating TRIM3. Taken together, our results suggested miR-4513 functions as an oncogene in the progression of BC and, therefore, miR-4513 may be validated as a potential therapeutic target in the future.

Entities:  

Keywords:  TRIM3; breast cancer; cell events; miR-4513; oncogene

Year:  2019        PMID: 31105849      PMCID: PMC6511807     

Source DB:  PubMed          Journal:  Am J Transl Res            Impact factor:   4.060


  10 in total

1.  Tripartite Motif Containing 3 inhibits the aggressive behaviors of papillary thyroid carcinoma and indicates lower recurrence risk.

Authors:  Yubao Song; Zefeng Gao; Zhifeng Yan; Caihong Zheng
Journal:  Genes Genomics       Date:  2021-12-03       Impact factor: 1.839

2.  Overexpression of TRIM3 protects against LPS-induced acute kidney injury via repressing IRF3 pathway and NLRP3 inflammasome.

Authors:  Weiwei Li; Yunzhi Tan; Feng Gao; Miaomiao Xiang
Journal:  Int Urol Nephrol       Date:  2021-10-13       Impact factor: 2.370

3.  Decreased expression of TRIM3 gene predicts a poor prognosis in gastric cancer.

Authors:  Javad Farhadi; Ladan Goshayeshi; Alireza Motavalizadehkakhky; Jamshid Mehrzad; Hassan Mehrad-Majd
Journal:  J Gastrointest Cancer       Date:  2021-01-07

Review 4.  Research progress on exosomal proteins as diagnostic markers of gastric cancer (review article).

Authors:  Hang Su; Weihong Ren; Dai Zhang
Journal:  Clin Exp Med       Date:  2022-01-22       Impact factor: 3.984

Review 5.  MicroRNAs and Epigenetics Strategies to Reverse Breast Cancer.

Authors:  Mohammad Mijanur Rahman; Andrew C Brane; Trygve O Tollefsbol
Journal:  Cells       Date:  2019-10-08       Impact factor: 6.600

6.  MiR-149-3p promotes the cisplatin resistance and EMT in ovarian cancer through downregulating TIMP2 and CDKN1A.

Authors:  Jin Wang; Lingxia Liu
Journal:  J Ovarian Res       Date:  2021-11-19       Impact factor: 4.234

7.  TRIM3 facilitates estrogen signaling and modulates breast cancer cell progression.

Authors:  Ting Zhuang; Beibei Wang; Xiaojing Tan; Le Wu; Xin Li; Zhongbo Li; Yuqing Cai; Rongrong Fan; Xiao Yang; Chenmiao Zhang; Yan Xia; Zhiguo Niu; Bingtian Liu; Qi Cao; Yinlu Ding; Zhipeng Zhou; Qingsong Huang; Huijie Yang
Journal:  Cell Commun Signal       Date:  2022-04-07       Impact factor: 5.712

8.  Signatures of genetic variation in human microRNAs point to processes of positive selection and population-specific disease risks.

Authors:  Hafid Laayouni; Yolanda Espinosa-Parrilla; Pablo Villegas-Mirón; Alicia Gallego; Jaume Bertranpetit
Journal:  Hum Genet       Date:  2022-03-06       Impact factor: 5.881

9.  TRIM3 and TRIM16 as potential tumor suppressors in breast cancer patients.

Authors:  Mohammad Reza Roshanazadeh; Maryam Adelipour; Arash Sanaei; Hadi Chenane; Mojtaba Rashidi
Journal:  BMC Res Notes       Date:  2022-09-30

10.  Seed sequence polymorphism rs2168518 and allele-specific target gene regulation of hsa-miR-4513.

Authors:  Christina Kiel; Tobias Strunz; Daniele Hasler; Gunter Meister; Felix Grassmann; Bernhard H F Weber
Journal:  Hum Mol Genet       Date:  2022-03-21       Impact factor: 6.150

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.